AZ SB1725

Limits total out-of-pocket costs for covered prescription insulin drugs to $100 per thirty-day supply across all health insurance plans, regardless of insulin type or quantity needed.

Applies to medical service corporations, hospital service corporations, health care services organizations, disability insurers, blanket disability insurers, and accountable health plans.

Defines "prescription insulin drug" as any prescription medication containing insulin prescribed by a health care professional to treat diabetes.

Allows insurers to continue imposing deductibles, coinsurance, and other cost-sharing measures for diabetes equipment and supplies, with the $100 limit applying specifically to insulin drugs.

Amends sections 20-826, 20-1057, 20-1342, 20-1402, 20-1404, and 20-2325 of Arizona Revised Statutes to implement the insulin cost-sharing cap across different insurance plan types.